Canaryspeech

Canary Speech is a healthcare technology company developing patented voice biomarker tools that use artificial intelligence to identify signals associated with mood, cognitive, behavioral, and neurological health. Its platform analyzes brief speech samples, with screening possible from 20 seconds of speech, and is designed to provide objective decision-support insights for clinicians and other healthcare stakeholders. The company aims to help replace subjective measurements with actionable data, support earlier detection, and improve patient outcomes across the care continuum.

Canary’s offerings include Canary Ambient, an ambient-listening tool intended to detect cognitive and behavioral conditions ahead of traditional screening and observable symptoms, as well as solutions for behavioral, cognitive, neurological, safety, and wellness applications. Its technology is available through an API-first platform and supports healthcare providers, payers, clinical trials, and clinical and contact centers. Canary also offers assessments and screening, API documentation, and iOS and Android apps. The company describes its cloud infrastructure as secure and scalable and states that its platform is HIPAA-compliant.